OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy
Xufeng Lu, Xiaohong Chen, Chengyin Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 55

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15

Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy
Yue Li, Zekun Du, Yuan Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 14

Tumor-colonizing Lachnoclostridium-mediated chemokine expression enhances the immune infiltration of bladder urothelial carcinoma
Liang Chen, Qingquan Xu, Weinan Chen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access

Antigen-presenting fibroblasts: emerging players in immune modulation and therapeutic targets
Xiaoyun Chen, Fangqi Chen, Sujie Jia, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3332-3344
Open Access

Identification and validation of SERPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC
Lingqin Li, Fan Li, Zhehao Xu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Clinical-mediated discovery of pyroptosis in CD8+ T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence
Ying Zhang, Yun Bai, Xiaoxuan Ma, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 9

Knowledge-map analysis of bladder cancer immunotherapy
Zongwei Lv, Junhui Hou, Yuan Wang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 7

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer
Reinhard Grausenburger, Paula Herek, Shahrokh F. Shariat, et al.
Current Opinion in Urology (2024) Vol. 34, Iss. 4, pp. 236-243
Open Access | Times Cited: 2

A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel
Haihong Hu, Ming‐Xiang Zou, Hongjuan Hu, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 4

Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis
Guangyao Lin, Huicong Liu, Jingyu Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3

A systematic review and meta-analysis of magnetic resonance and computed tomography enterography in the diagnosis of small intestinal tumors
Ruitao Li, Shengqiang Ye, Chenglong Zhou, et al.
PeerJ (2023) Vol. 11, pp. e16687-e16687
Open Access | Times Cited: 2

Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer
Haihong Hu, Hongxia Zhu, Wendi Zhan, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 1047-1068
Closed Access

Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer
Zhenyu Nie, Bolong Liu, Jinhui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top